Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Filed Oct 29, 2012 · 10-K · 90 days after period end · 0001079973-12-000838
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|
| Revenue | $127.00K | $245.00K |
| Net Income | -$2.51M | -$2.03M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
ended Jul 31, 2012 · filed Oct 29, 2012 · 90 d after period end
